Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)
Clinical trial NCT01508156 · COMPLETED
Trial details
- NCT number
- NCT01508156
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.